Ibrahima Cheikh Diong,director-designate,The Fund for Responding to...
Category:
Eco/Invest/Demography
Latest
GoM on GST rate rationalisation to meet on Sep 25 to discuss slab, rate tweaks
During the August meeting, the panel had tasked the fitment...
Total AUM for Indian gold ETFs climbs to Rs 374 billion by the end of August
Total assets under management (AUM) for Indian gold ETFs climbed to...
Adani and other Australian coal miners flag finance, insurance difficulties
The withdrawal of global insurers risks making even some ancillary business unviable, said contractor BMD Constructions Pty Ltd, which is building a section of a 210 km (130 mile) rail line to service Adani’s Carmichael mine in northern Queensland state, which is due to start operating this year.
The coal miners argued that Australia’s high-energy coal offers a comparatively lower emissions alternative to export markets compared with coal from other regions. They say coal also provides billions of dollars to government coffers and supports regional jobs.
Indian states turn to anti-parasitic drug to fight COVID-19 against WHO advice
“The current evidence on the use of ivermectin to treat COVID-19 patients is inconclusive,” WHO said in a statement in late March. “Until more data is available, WHO recommends that the drug only be used within clinical trials.”
Merck, a manufacturer of the drug, has also said available data does not support using the drug as a COVID-19 treatment. “We do not have enough data to support its use,” said Anita Mathew, an infectious diseases expert in Mumbai.
Fire tragedy: FIR against trustees of Bharuch hospital
Sixteen COVID-19 patients and two trainee nurses died in the blaze in the ICU ward of the ‘Welfare Hospital’, run by a charitable trust, on May 1.
The FIR was registered against the Bombay Patel Welfare Society’s president, Khalid Patel, other trustees and key functionaries of the trust which runs the hospital, Parmar said, adding that no one has been arrested so far.
Slum-dwellers, homeless people move Delhi HC for direction to provide food, shelter, financial help
“As per the report 1.77 million Indians are homeless and 40 per cent of them are even getting no lockdown relief,” the plea stated.
“The problem is especially acute for homeless women who are malnourished and suffer from various other diseases, mental health issues and risky pregnancies. With hospitals overburdened with COVID-19, the issue of accessibility is likely to be worse now,” the plea read.
Peak will come, virus can again emerge: Govt
NITI Aayog member (health) Dr V K Paul said it is the nature of the disease that it will ultimately go to villages.
This epidemiology is well known, Paul said as he urged people to follow COVID appropriate behaviour and embrace vaccination.
So peak will come, the virus can again emerge, we know. So preparations have to be made at country level in collaboration with states, infrastructure has to be ramped up, containment measures have to be implemented and COVID appropriate behaviour has to be followed, he said.
216 cr vaccine doses to be available in 5 months between Aug-Dec, enough to cover all: Centre
Further, Biological E is expected to produce 30 crore doses, Zydus Cadila 5 crore, Serum Institute of India 20 crore doses of Novavax, and Bharat Biotech 10 crore doses of its nasal vaccine, while Gennova will make available 6 crore doses and Sputnik V 15.6 crore doses, he said. The vaccine candidates of Biological E, Zydus Cadila, Gennova, Bharat Biotech’s nasal vaccine are in various stages of clinical trials.
Mixing AstraZeneca and Pfizer shots triggers more fatigue, headaches: Study
Researchers and public health officials are examining strategies such as blending two different shots as many low- and middle-income nations try to figure out how to cope with vaccine scarcity. Assurance that mismatched shots are still safe and effective would make it easier for governments to manage their stockpiles and provide more insight into a combination that’s already used in some countries.
Gap between two doses of Covishield extended to 12-16 weeks: Govt
the National Technical Advisory Group on Immunisation (NTAGI) has suggested no change for the dosage interval for Covaxin, the ministry said.
“Based on the available real-life evidences, particularly from the UK, the COVID-19 Working Group agreed for increasing the dosing interval to 12-16 weeks between two doses of Covishield vaccine. No change in interval of Covaxin vaccine doses was recommended,” the ministry said.
The present gap between two doses of Covishield, manufactured by the Serum Institute of India, is 6-8 weeks.
Government pro-actively looking for action on WhatsApp privacy rules issue: MeitY official
“The ministry is cognisant of this problem. Today, Germany has banned this privacy policy of WhatsApp. The ministry is proactively looking at what we can do about it,” MeitY Special Secretary and Financial Advisor Jyoti Arora said at an Assocham event.
Many COVID-19 experts believe time for Americans to ditch the mask rule
Right now, the vaccination figure is around 59 per cent of adults with at least one dose, while the country is reporting around 38,000 daily new cases — a per capita rate of 11 new cases per 100,000 people, well below global hotspots and falling fast.
According to New York Times, as of Wednesday, about 154 million people have received at least one dose of a Covid-19 vaccine, but only about one-third of the nation, some 117.6 million people, have been fully vaccinated.